265
Views
0
CrossRef citations to date
0
Altmetric
In vitro and animal studies

Dietary chlorogenic acid alleviates high-fat diet-induced steatotic liver disease by regulating metabolites and gut microbiota

, , , , , , & ORCID Icon show all
Pages 369-384 | Received 01 Sep 2023, Accepted 05 Feb 2024, Published online: 22 Feb 2024

References

  • Abenavoli L, Falalyeyeva T, Boccuto L, Tsyryuk O, Kobyliak N. 2018. Obeticholic acid: a new era in the treatment of nonalcoholic fatty liver disease. Pharmaceuticals. 11(4):11. doi: 10.3390/ph11040104.
  • Aoki R, Aoki-Yoshida A, Suzuki C, Takayama Y. 2018. Indole-3-pyruvic acid, an aryl hydrocarbon receptor activator, suppresses experimental colitis in mice. J Immunol. 201(12):3683–3693. doi: 10.4049/jimmunol.1701734.
  • Cai W, Xu J, Li G, Liu T, Guo X, Wang H, Luo L. 2020. Ethanol extract of propolis prevents high-fat diet-induced insulin resistance and obesity in association with modulation of gut microbiota in mice. Food Res Int. 130:108939. doi: 10.1016/j.foodres.2019.108939.
  • Cajka T, Fiehn O. 2016. Toward merging untargeted and targeted methods in mass spectrometry-based metabolomics and lipidomics. Anal Chem. 88(1):524–545. doi: 10.1021/acs.analchem.5b04491.
  • Cardiff RD, Miller CH, Munn RJ. 2014. Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb Protoc. 2014(6):655–658. doi: 10.1101/pdb.prot073411.
  • Chen L, Kan J, Zheng N, Li B, Hong Y, Yan J, Tao X, Wu G, Ma J, Zhu W, et al. 2021. A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation. Phytomedicine. 91:153693. doi: 10.1016/j.phymed.2021.153693.
  • Cui Y, Zhang L, Wang X, Yi Y, Shan Y, Liu B, Zhou Y, Lü X. 2022. Roles of intestinal Parabacteroides in human health and diseases. FEMS Microbiol Lett. 369(1):fnac072. doi: 10.1093/femsle/fnac072.
  • Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. 1976. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery. 80:77–91.
  • Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. 2018. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 24(7):908–922. doi: 10.1038/s41591-018-0104-9.
  • Hou Q, Ye L, Liu H, Huang L, Yang Q, Turner JR, Yu Q. 2018. Lactobacillus accelerates ISCs regeneration to protect the integrity of intestinal mucosa through activation of STAT3 signaling pathway induced by LPLs secretion of IL-22. Cell Death Differ. 25(9):1657–1670. doi: 10.1038/s41418-018-0070-2.
  • Huang Z, Chang C. 2008. Advances of study on glucose and lipids metabolism of chlorogenic acid regulating. Wei Sheng Yan Jiu. 37:637–639.
  • Ji L, Jiang P, Lu B, Sheng Y, Wang X, Wang Z. 2013. Chlorogenic acid, a dietary polyphenol, protects acetaminophen-induced liver injury and its mechanism. J Nutr Biochem. 24(11):1911–1919. doi: 10.1016/j.jnutbio.2013.05.007.
  • Kim DJ, Yoon S, Ji SC, Yang J, Kim Y-K, Lee S, Yu K-S, Jang I-J, Chung J-Y, Cho J-Y, et al. 2019. Author correction: ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction. Sci Rep. 9(1):17003. doi: 10.1038/s41598-019-53737-7.
  • Klein EA, Thompson IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, et al. 2011. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 306(14):1549–1556. doi: 10.1001/jama.2011.1437.
  • Koh GY, Kane AV, Wu X, Crott JW. 2020. Parabacteroides distasonis attenuates tumorigenesis, modulates inflammatory markers and promotes intestinal barrier integrity in azoxymethane-treated A/J mice. Carcinogenesis. 41(7):909–917. doi: 10.1093/carcin/bgaa018.
  • Krishnan S, Ding Y, Saedi N, Choi M, Sridharan GV, Sherr DH, Yarmush ML, Alaniz RC, Jayaraman A, Lee K, et al. 2018. Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages. Cell Rep. 23(4):1099–1111. doi: 10.1016/j.celrep.2018.03.109.
  • Lagkouvardos I, Lesker TR, Hitch TCA, Gálvez EJC, Smit N, Neuhaus K, Wang J, Baines JF, Abt B, Stecher B, et al. 2019. Sequence and cultivation study of Muribaculaceae reveals novel species, host preference, and functional potential of this yet undescribed family. Microbiome. 7(1):28. doi: 10.1186/s40168-019-0637-2.
  • Lai H-C, Lin T-L, Chen T-W, Kuo Y-L, Chang C-J, Wu T-R, Shu C-C, Tsai Y-H, Swift S, Lu C-C, et al. 2022. Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide. Gut. 71(2):309–321. doi: 10.1136/gutjnl-2020-322599.
  • Liu H, Liao C, Wu L, Tang J, Chen J, Lei C, Zheng L, Zhang C, Liu Y-Y, Xavier J, et al. 2022. Ecological dynamics of the gut microbiome in response to dietary fiber. ISME J. 16(8):2040–2055. doi: 10.1038/s41396-022-01253-4.
  • Ma Q, Chen J, Zhou X, Hu L, Sun Y, Wang Z, Yue Z, Shan A. 2021. Dietary supplementation with aromatic amino acids decreased triglycerides and alleviated hepatic steatosis by stimulating bile acid synthesis in mice. Food Funct. 12(1):267–277. doi: 10.1039/d0fo02364g.
  • Mahmoodi S, Yousefi M, Sadeghi O, Mahmoodabadi A, Sadriirani M, Hosseinzade Z, Jahanbakhsh A, Panahande SB, Saeedinejad Z, Malekzadeh JM, et al. 2020. Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized clinical trials. Trials. 22(1):514. doi: 10.1002/ptr.6637.
  • Masoodi M, Gastaldelli A, Hyötyläinen T, Arretxe E, Alonso C, Gaggini M, Brosnan J, Anstee QM, Millet O, Ortiz P, et al. 2021. Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests. Nat Rev Gastroenterol Hepatol. 18(12):835–856. doi: 10.1038/s41575-021-00502-9.
  • Nabavi SF, Tejada S, Setzer WN, Gortzi O, Sureda A, Braidy N, Daglia M, Manayi A, Nabavi SM. 2017. Chlorogenic acid and mental diseases: from chemistry to medicine. Curr Neuropharmacol. 15(4):471–479. doi: 10.2174/1570159x14666160325120625.
  • Nassir F. 2022. NAFLD: mechanisms, treatments, and biomarkers. Biomolecules. 12(6):12. doi: 10.3390/biom12060824.
  • Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, et al. 2009. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9(4):311–326. doi: 10.1016/j.cmet.2009.02.002.
  • Neyrinck AM, Etxeberria U, Taminiau B, Daube G, Van Hul M, Everard A, Cani PD, Bindels LB, Delzenne NM. 2017. Rhubarb extract prevents hepatic inflammation induced by acute alcohol intake, an effect related to the modulation of the gut microbiota. Mol Nutr Food Res. 61. doi: 10.1002/mnfr.201500899.
  • Piras C, Noto A, Ibba L, Deidda M, Fanos V, Muntoni S, Leoni VP, Atzori L. 2021. Contribution of metabolomics to the understanding of NAFLD and NASH syndromes: a systematic review. Metabolites. 11(10):11. doi: 10.3390/metabo11100694.
  • Sakata R, Nakamura T, Torimura T, Ueno T, Sata M. 2013. Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study. Int J Mol Med. 32(5):989–994. doi: 10.3892/ijmm.2013.1503.
  • Scalbert A, Williamson G. 2000. Dietary intake and bioavailability of polyphenols. J Nutr. 130(8S Suppl.):2073s–2085s. doi: 10.1093/jn/130.8.2073S.
  • Teymoori F, Asghari G, Salehi P, Sadeghian S, Mirmiran P, Azizi F. 2019. Are dietary amino acids prospectively predicts changes in serum lipid profile? Diabetes Metab Syndr. 13(3):1837–1843. doi: 10.1016/j.dsx.2019.04.013.
  • Tsou AM, Goettel JA, Bao B, Biswas A, Kang YH, Redhu NS, Peng K, Putzel GG, Saltzman J, Kelly R, et al. 2021. Utilizing a reductionist model to study host–microbe interactions in intestinal inflammation. Microbiome. 9(1):215. doi: 10.1186/s40168-021-01161-3.
  • Vauzour D, Rodriguez-Ramiro I, Rushbrook S, Ipharraguerre IR, Bevan D, Davies S, Tejera N, Mena P, de Pascual-Teresa S, Del Rio D, et al. 2018. n-3 Fatty acids combined with flavan-3-ols prevent steatosis and liver injury in a murine model of NAFLD. Biochim Biophys Acta Mol Basis Dis. 1864(1):69–78. doi: 10.1016/j.bbadis.2017.10.002.
  • Verdam FJ, Fuentes S, de Jonge C, Zoetendal EG, Erbil R, Greve JW, Buurman WA, de Vos WM, Rensen SS. 2013. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity. 21(12):E607–E615. doi: 10.1002/oby.20466.
  • Wu T-R, Lin C-S, Chang C-J, Lin T-L, Martel J, Ko Y-F, Ojcius DM, Lu C-C, Young JD, Lai H-C, et al. 2019. Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut. 68(2):248–262. doi: 10.1136/gutjnl-2017-315458.
  • Xie MG, Fei YQ, Wang Y, Wang WY, Wang Z. 2021. Chlorogenic acid alleviates colon mucosal damage induced by a high-fat diet via gut microflora adjustment to increase short-chain fatty acid accumulation in rats. Oxid Med Cell Longev. 2021:3456542. doi: 10.1155/2021/3456542.
  • Ye J, Zhao Y, Chen X, Zhou H, Yang Y, Zhang X, Huang Y, Zhang N, Lui EMK, Xiao M, et al. 2021. Pu-erh tea ameliorates obesity and modulates gut microbiota in high fat diet fed mice. Food Res Int. 144:110360. doi: 10.1016/j.foodres.2021.110360.
  • Zhou D, Fan JG. 2019. Microbial metabolites in non-alcoholic fatty liver disease. World J Gastroenterol. 25(17):2019–2028. doi: 10.3748/wjg.v25.i17.2019.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.